Sanofi

Sanofi R&D per Employee

The R&D Spending per Employee of Sanofi (SAN.PA) as of Nov 6, 2026 is 78,883.84 EUR. In the previous year, R&D Spending per Employee was 74,377.34 EUR — a change of 6.06% (higher).

R&D per Employee

78,883.84EUR

YoY

6.06%

Last updated:

R&D Spending per Employee of Sanofi is 2025 78,883.84 EUR. R&D Spending per Employee of Sanofi was 2024 74,377.34 EUR. It decreases by 6.06% higher compared to the previous year.

The Sanofi R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2018
63,875.59 EUR
Jan 1, 2019
60,556.07 EUR
Jan 1, 2020
55,627.09 EUR
Jan 1, 2021
57,256.67 EUR
Jan 1, 2022
65,394.52 EUR
Jan 1, 2023
65,454.87 EUR
Jan 1, 2024
74,377.34 EUR
Jan 1, 2025
78,883.84 EUR
The Sanofi R&D per Employee history
YEARR&D per EmployeeYoY
78,883.84EUR+6.06%
74,377.34EUR+13.63%
65,454.87EUR+0.09%
65,394.52EUR+14.21%
57,256.67EUR+2.93%
55,627.09EUR-8.14%
60,556.07EUR-5.20%
63,875.59EUR+14.07%
55,999.28EUR+6.40%
52,629.46EUR+2.95%
51,120.59EUR+8.89%
46,946.04EUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sanofi Stock analysis

What does Sanofi do? Sanofi SA is a French company that was formed in 1973 from a merger of two French pharmaceutical and biotechnology companies. It is one of the largest players in the healthcare industry worldwide and employs over 100,000 employees. The objective of Sanofi is to improve people's lives through innovative medicines and therapies. In this regard, the company pursues a comprehensive business model that focuses on both research and development, as well as the production and distribution of medications and vaccines. The company has different divisions and product lines, which are divided into three business areas: Innovative Medicine, Consumer Healthcare, and Generic Pharmaceuticals. Innovative Medicine utilizes state-of-the-art technologies and scientific knowledge to treat the most challenging diseases. In the area of Consumer Healthcare, the company offers a wide range of over-the-counter products such as vitamins, dietary supplements, cough and cold remedies, as well as oral and dental health products. In the Generic Pharmaceuticals field, the company produces more cost-effective alternatives to expensive brand-name products, providing a variety of generic medications. Sanofi is a leading manufacturer of medications that are of great significance in various areas such as diabetes, oncology, cardiovascular diseases, and neurology. In recent years, the company has also established a strong presence in the field of vaccines. Here, Sanofi develops and produces innovative vaccines against COVID-19, influenza, and other infectious diseases. Sanofi is present in more than 170 countries and collaborates closely with physicians, research institutions, and health authorities to improve healthcare worldwide. The company conducts research and development in various disciplines and invests a significant amount each year in the development of innovative medicines and therapies. Overall, Sanofi SA is an emerging company in the pharmaceutical and healthcare sector. The portfolio of products and therapies offered by Sanofi is extensive and covers many areas of healthcare. Sanofi relies on continuous innovation and continuously works to improve healthcare and enhance the lives of people worldwide. Sanofi is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sanofi stock

R&D Spending per Employee of Sanofi is 78,883.84 EUR in 2025.

R&D Spending per Employee of Sanofi changed from 74,377.34 EUR to 78,883.84 EUR, representing a 6.06% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Sanofi since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Sanofi historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Sanofi

All Key Metrics — Sanofi